Cargando…
Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series
BACKGROUND: Refractory migraine is a challenging condition with great impact on health related quality of life. Intravenous (IV) ketamine has been previously used to treat various refractory pain conditions. We present a series of patients with refractory migraine treated with intravenous ketamine i...
Autores principales: | Lauritsen, Clinton, Mazuera, Santiago, Lipton, Richard B., Ashina, Sait |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120050/ https://www.ncbi.nlm.nih.gov/pubmed/27878523 http://dx.doi.org/10.1186/s10194-016-0700-3 |
Ejemplares similares
-
Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine
por: Mojica, Jeffrey J., et al.
Publicado: (2021) -
Depression and risk of transformation of episodic to chronic migraine
por: Ashina, Sait, et al.
Publicado: (2012) -
Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
por: Zheng, Wei, et al.
Publicado: (2021) -
Structural and Functional Brain Changes in Migraine
por: Ashina, Sait, et al.
Publicado: (2021) -
Stem Cells in the Treatment of Refractory Chronic Migraines
por: Mauskop, Alexander, et al.
Publicado: (2017)